First Hawaiian Bank’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

First Hawaiian Bank’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-86	Closed	-$3K	–	1661
2019 Q1	$3K	Buy	86 +26	+43%	+$750	﹤0.01%	1611
2018 Q4	$1K	Hold	60	–	–	﹤0.01%	1799
2018 Q3	$2K	Buy	+60	New	+$1.96K	﹤0.01%	1778

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

First Hawaiian Bank's PTLA Position: Q2 2019 in Review

First Hawaiian Bank sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2019, closing a stake of 86 shares — an estimated $3K sold.

First Hawaiian Bank first reported a position in PTLA in Q3 2018 and held it in 3 quarters. The position peaked at $3K in Q1 2019. 202 funds tracked by Wall St. Rank hold PTLA as of Q2 2019.

First Hawaiian Bank reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 86 Portola Pharmaceuticals, Inc. shares in Q2 2019, an estimated $3K.
First Hawaiian Bank first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 3 quarters.
First Hawaiian Bank's Portola Pharmaceuticals, Inc. position peaked at $3K in Q1 2019.
202 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.